News Sentiment

SLS sentiment intelligence

Sellas Life Sciences Group Inc news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report Factors RSS feed
Weighted score 58 Balanced news tone 55 relevant articles
Exchange NASDAQ United States
Sector Healthcare Market context
Industry Biotechnology Read-through group
Latest close 13.19 Week of 17 Jul 2026
Weighted tone 58/100

Balanced news tone

Market reaction Balanced read

News tone and price action are not far from neutral.

Primary event Market update

77/100 classification confidence.

Company focus 46

directly relevant articles

Source quality 1

high-authority source matches

Trend context Trend active

+3.4% over one week, +63.9% over four weeks, trend active, and materially above fair value.

Latest direct headline Negative

SELLAS Life Sciences Group Stock Short Interest Falls to 32.33%

Market Reaction

Balanced read

67/100 confidence

News tone and price action are not far from neutral.

Primary event Market update 77/100 classification
One-week reaction 3.4% Price confirming higher
Trend fit Trend active 63.9% over four weeks
Fair value 472.7% Materially above fair value

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 23
Neutral 24
Negative 8

Relevance

Why the article matched

Direct first
Direct company coverage 46
Industry context 9
Sector context 0

Sources

Coverage mix

Publishers
Market source 14
simplywall.st 8
TradingView 6
StocksToTrade 4
Stocktwits 3
Moomoo 3
Quiver Quantitative 2
TechStock² 2

Event Lens

What the news is about

Classified themes
Market update 25
Earnings 17
Analyst action 4
Deals and strategy 4
Balance sheet 3
Guidance 1
Regulatory and legal 1

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 31-55 of 55
Timothy Sykes Direct company coverage

SLS Stock Extends Meme-Style Rally On WallStreetBets Buzz

SELLAS Life Sciences Group Inc. (SLS) stock extended a meme-style rally driven by WallStreetBets buzz, not new fundamentals or clinical data. Despite trading down 7.9% on trial-related news, the stock had seen a significant surge, reflecting high volatility common in low-float bi

Tone
Negative 38/100
Event
Market update
Published
30 Jun 2026 15:39
Source
Timothy Sykes
StocksToTrade Direct company coverage

SLS Stock Extends Run As Cash Pile Fuels Speculative Trading

SELLAS Life Sciences Group Inc. (SLS) has seen its stock surge due to promising oncology trial progress and its substantial cash reserves, making it attractive for speculative trading. Despite operating at a loss, the company's strong balance sheet with $107.1M in cash against mi

Tone
Neutral 50/100
Event
Balance sheet
Published
29 Jun 2026 16:32
Source
StocksToTrade
TradingView Direct company coverage

Enterprise value to revenue forward of SELLAS Life Sciences Group, Inc. – NASDAQ:SLS

This article provides the enterprise value to revenue forward for SELLAS Life Sciences Group, Inc. (NASDAQ:SLS). The information is presented within the context of financial data available on TradingView, specifically under the "Financials" section for the company.

Tone
Neutral 50/100
Event
Earnings
Published
27 Jun 2026 08:40
Source
TradingView
TradingView Direct company coverage

Price to earnings forward of SELLAS Life Sciences Group, Inc. – HAM:RXK3

The article focuses on the "Price to earnings forward" metric for SELLAS Life Sciences Group, Inc. (HAM:RXK3) on the Hamburg Stock Exchange. Although the content provides extensive navigation and data source information, it explicitly states that the stock market is currently clo

Tone
Neutral 50/100
Event
Earnings
Published
27 Jun 2026 00:39
Source
TradingView
Blockonomi Direct company coverage

SELLAS Life Sciences (SLS) Stock Soars 17% on Executive Contract Overhaul and M&A Buzz

SELLAS Life Sciences (SLS) stock surged over 17% to a new 52-week high after the company revised executive contracts to include change-of-control severance packages and accelerated equity vesting, often signaling potential M&A activity. This comes as the company's critical Phase

Tone
Positive 90/100
Event
Deals and strategy
Published
26 Jun 2026 14:11
Source
Blockonomi
StocksToTrade Direct company coverage

SLS Stock Surges As Cash Pile Fuels Biotech Momentum

SELLAS Life Sciences Group Inc. (SLS) stock surged by 14.62% due to advancements in its oncology pipeline. Despite being revenue-light and operating at a loss, the biotech company holds a significant cash reserve of $107.1 million, enabling it to fund trials and drive catalyst-dr

Tone
Positive 74/100
Event
Balance sheet
Published
26 Jun 2026 12:32
Source
StocksToTrade
Stocktwits Direct company coverage

SLS Short Interest Hits All-Time High: Sellas Bulls Smell A Short Squeeze As Executive Contract Changes Fuel Buyout Chatter

Sellas Life Sciences (SLS) saw its short interest climb to a record high of nearly 33% of the float, fueling speculation of a potential short squeeze among bullish investors. This comes alongside renewed buyout chatter, driven by recent changes to executive severance agreements w

Tone
Positive 74/100
Event
Deals and strategy
Published
26 Jun 2026 06:53
Source
Stocktwits
TradingView Direct company coverage

SELLAS Life Sciences Group, Inc. Actuals & Estimates (NASDAQ:SLS)

This article provides a detailed overview of SELLAS Life Sciences Group, Inc. (NASDAQ: SLS) stock, including its current price, performance, analyst forecasts, and financial data. It highlights the stock's significant increase over the last year, its volatility, and upcoming earn

Tone
Positive 70/100
Event
Analyst action
Published
26 Jun 2026 03:10
Source
TradingView
Market source Direct company coverage

Sellas (SLS) Extends Rally, New Filing Hints at Company Takeover

Sellas Life Sciences (SLS) stock extended its rally for a sixth consecutive session, closing up 14.83% after a regulatory filing suggested a potential company takeover. The filing disclosed amendments to employment and severance agreements for three top executives, providing lump

Tone
Positive 66/100
Event
Regulatory and legal
Published
25 Jun 2026 21:09
Source
Market source
24/7 Wall St. Direct company coverage

Sellas Life Sciences Group : SLS

Tone
Neutral 50/100
Event
Market update
Published
20 Mar 2026 07:00
Source
24/7 Wall St.